Free Trial

Vigil Neuroscience (VIGL) Competitors

Vigil Neuroscience logo
$8.05 -0.02 (-0.25%)
Closing price 04:00 PM Eastern
Extended Trading
$8.06 +0.01 (+0.19%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VIGL vs. NVTS, VERA, TVTX, EWTX, EVO, BHVN, MESO, ANIP, HROW, and PAHC

Should you be buying Vigil Neuroscience stock or one of its competitors? The main competitors of Vigil Neuroscience include Navitas Semiconductor (NVTS), Vera Therapeutics (VERA), Travere Therapeutics (TVTX), Edgewise Therapeutics (EWTX), Evotec (EVO), Biohaven (BHVN), Mesoblast (MESO), ANI Pharmaceuticals (ANIP), Harrow (HROW), and Phibro Animal Health (PAHC).

Vigil Neuroscience vs. Its Competitors

Vigil Neuroscience (NASDAQ:VIGL) and Navitas Semiconductor (NASDAQ:NVTS) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Vigil Neuroscience has a net margin of 0.00% compared to Navitas Semiconductor's net margin of -131.83%. Navitas Semiconductor's return on equity of -22.62% beat Vigil Neuroscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Vigil NeuroscienceN/A -111.70% -74.67%
Navitas Semiconductor -131.83%-22.62%-20.38%

In the previous week, Navitas Semiconductor had 13 more articles in the media than Vigil Neuroscience. MarketBeat recorded 13 mentions for Navitas Semiconductor and 0 mentions for Vigil Neuroscience. Navitas Semiconductor's average media sentiment score of 0.62 beat Vigil Neuroscience's score of 0.00 indicating that Navitas Semiconductor is being referred to more favorably in the news media.

Company Overall Sentiment
Vigil Neuroscience Neutral
Navitas Semiconductor Positive

Vigil Neuroscience presently has a consensus target price of $10.80, indicating a potential upside of 34.16%. Navitas Semiconductor has a consensus target price of $3.71, indicating a potential downside of 58.70%. Given Vigil Neuroscience's higher possible upside, analysts plainly believe Vigil Neuroscience is more favorable than Navitas Semiconductor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vigil Neuroscience
0 Sell rating(s)
10 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Navitas Semiconductor
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

83.6% of Vigil Neuroscience shares are owned by institutional investors. Comparatively, 46.1% of Navitas Semiconductor shares are owned by institutional investors. 18.0% of Vigil Neuroscience shares are owned by insiders. Comparatively, 29.9% of Navitas Semiconductor shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Vigil Neuroscience has higher earnings, but lower revenue than Navitas Semiconductor. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93
Navitas Semiconductor$83.30M20.68-$84.60M-$0.52-17.27

Vigil Neuroscience has a beta of 3.34, indicating that its share price is 234% more volatile than the S&P 500. Comparatively, Navitas Semiconductor has a beta of 3.01, indicating that its share price is 201% more volatile than the S&P 500.

Summary

Navitas Semiconductor beats Vigil Neuroscience on 9 of the 15 factors compared between the two stocks.

Get Vigil Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VIGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VIGL vs. The Competition

MetricVigil NeuroscienceMED IndustryMedical SectorNASDAQ Exchange
Market Cap$383.91M$3.06B$5.67B$9.50B
Dividend YieldN/A2.44%4.05%4.00%
P/E Ratio-3.9320.9027.9219.98
Price / SalesN/A245.97397.1882.73
Price / CashN/A41.9636.1958.45
Price / Book4.608.288.635.82
Net Income-$84.26M-$55.19M$3.24B$258.42M
7 Day Performance-0.37%5.09%3.17%1.94%
1 Month Performance1.51%17.64%10.73%12.08%
1 Year Performance89.41%7.03%35.04%20.90%

Vigil Neuroscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIGL
Vigil Neuroscience
3.4038 of 5 stars
$8.05
-0.2%
$10.80
+34.2%
+102.3%$383.91MN/A-3.9340
NVTS
Navitas Semiconductor
1.0671 of 5 stars
$5.87
+0.5%
$3.71
-36.8%
+112.0%$1.13B$74.15M-11.29160Options Volume
VERA
Vera Therapeutics
4.2391 of 5 stars
$23.78
-0.2%
$65.00
+173.3%
-35.5%$1.52BN/A-7.9340
TVTX
Travere Therapeutics
2.9838 of 5 stars
$16.91
+2.7%
$32.14
+90.1%
+64.9%$1.50B$233.18M-6.02460Positive News
Upcoming Earnings
EWTX
Edgewise Therapeutics
1.7189 of 5 stars
$13.93
+0.7%
$40.00
+187.2%
-33.9%$1.47BN/A-8.9960
EVO
Evotec
2.079 of 5 stars
$4.12
+1.2%
$5.93
+44.0%
-20.1%$1.46B$862.40M0.004,827Gap Up
BHVN
Biohaven
2.4144 of 5 stars
$14.18
+1.8%
$58.46
+312.2%
-63.7%$1.45BN/A-1.52239
MESO
Mesoblast
0.9159 of 5 stars
$11.17
+0.5%
$18.00
+61.1%
+94.6%$1.43B$5.90M0.0080Upcoming Earnings
Gap Up
ANIP
ANI Pharmaceuticals
3.771 of 5 stars
$65.19
+0.4%
$78.88
+21.0%
+3.4%$1.41B$674.07M-51.33600News Coverage
HROW
Harrow
2.5949 of 5 stars
$35.62
+2.0%
$63.83
+79.2%
+50.9%$1.31B$199.61M-63.61180
PAHC
Phibro Animal Health
4.069 of 5 stars
$31.54
+2.4%
$24.40
-22.6%
+57.5%$1.28B$1.02B40.441,940Positive News

Related Companies and Tools


This page (NASDAQ:VIGL) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners